Characterization of N-glycosylation profiles from mammalian and insect cell derived chikungunya VLP
Keywords: Chikungunya; Vaccine; VLP; Glycosylation; HILIC;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Quantitative and epitope-specific antigenicity analysis of the human papillomavirus 6 capsid protein in aqueous solution or when adsorbed on particulate adjuvants
Keywords: HPV; human papillomavirus; VLP; recombinant virus-like particle; mAb; monoclonal antibody; PsV; pseudovirus; HRP; horseradish peroxidase; GFP; green fluorescent protein; HAI; hemagglutination inhibition; CSI; conformational sensitivity index; Human papill
Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines
Keywords: HIV; human immunodeficiency virus; AIDS; acquired immunodeficiency syndrome; HCV; hepatitis C virus; LAV; live attenuated viral vaccines; VLP; virus-like particles; IM; intramuscular; ID; intradermal; DC; dendritic cells; APC; antigen presenting cells; Th
A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men
Keywords: 9vHPV vaccine; 9-valent HPV vaccine; AE; adverse event; ANOVA; analysis of variance; CI; confidence interval; cLIA; competitive Luminex immunoassay; EU; European Union; GMTs; geometric mean titres; HPV; human papilloma virus; qHPV vaccine; quadrivalent HP
Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model
Keywords: Influenza; Virus-like particles; VLP; H10N8; Recombinant vaccine; Baculovirus;
Particle and subunit-based hemagglutinin vaccines provide protective efficacy against H1N1 influenza in pigs
Keywords: Influenza; Swine; Vaccine; Hemagglutinin; Baculovirus; Subunit; VLP
Structure of AP205 Coat Protein Reveals Circular Permutation in ssRNA Bacteriophages
Keywords: ssRNA; single-stranded RNA; VLP; virus-like particle; MAS; magic-angle spinning; 3D; three-dimensional; SeMet; selenomethionine Tobacco Etch Virus, TEV; cryo-EM; cryo-electron microscopy; RNA bacteriophage; Leviviridae; coat protein; virus-like particle;
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor
Keywords: Aggressiveness; Neuropeptide S; Neuropeptide S receptor; Resident/intruder test; Mice; NPSR knockout mice; [tBu-D-Gly5]NPS; SHA 68; NPS; neuropeptide S; NPSR; NPS receptor; NPSR(+/+); NPSR wild type; NPSR(â/â); NPSR knockout; VLP; valproate;
Prevalence of Groups A and C Rotavirus Antibodies in Infants with Biliary Atresia and Cholestatic Controls
Keywords: BA; Biliary atresia; BARC; Biliary Atresia Research Consortium; EIU; Enzyme-linked immunoassay unit; ELISA; Enzyme-linked immunosorbent assay; OD; Optical density; RV; Rotavirus; RRV; Rhesus rotavirus; RV-A; Group A RV; RV-C; Group C RV; VLP; Virus-like p
Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014
Keywords: ADCC; antibody-dependent cell-mediated cytotoxicity; CMI; cell-mediated immunity; COBRA; computationally optimized broadly reactive antigen; CoP; immune correlate of protection; HA; influenza haemagglutinin protein; HI; haemagglutination inhibition; IFN;
Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus
Keywords: Influenza; H7N9; Influenza vaccine; Virus-like particles; VLP;
HIV-1 matrix domain removal ameliorates virus assembly and processing defects incurred by positive nucleocapsid charge elimination
Keywords: CA; capsid; MA; matrix; NC; nucleocapsid; PR; viral protease; VLP; virus-like particle; HIV-1; Virus assembly; Gag cleavage; Nucleocapsid; Matrix; Membrane association;
Mutations in the alpha-helical region of the amino terminus of the Maize rayado fino virus capsid protein and CP:RNA ratios affect virus-like particle encapsidation of RNAs
Keywords: Viral-like particle; RNA encapsidation; VLP; Nanoparticle; Protein cage; Maize rayado fino virus;
Effective cutaneous vaccination using an inactivated chikungunya virus vaccine delivered by Foroderm
Keywords: Vaccine delivery; Cutaneous vaccination; Chikungunya virus; Foroderm; CHIKV; chikungunya virus; VLP; virus like particle; cpm; counts per minute;
Multi-enveloping of particulated antigens with biopolymers and immunostimulant polynucleotides
Keywords: Hepatitis B; VLP; Multi-enveloped nanoparticle; Polyamino acid; Polysaccharide; Poly (I:C)
Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes
Keywords: Human papillomavirus; HPV16; HPV31; L2; Neutralizing antibody; Vaccine; VLP; AAV2; Adeno-associated virus; Display; Challenge; Adjuvant;
Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling
Keywords: BKPyV; BK polyomavirus; ELISA; enzyme-linked immunosorbent assay; HPyV; human polyomavirus; Ig; immunoglobulin; JCPyV; JC polyomavirus; MS; multiple sclerosis; PML; progressive multifocal leukoencephalopathy; nOD; normalized optical density; PyVHC; polyom
Norovirus P particle: An excellent vaccine platform for antibody production against Alzheimer's disease
Keywords: AD; Alzheimer disease; NoV; Noroviruses; BBB; blood-brain barrier; TEM; transmission electron microscopy; VLP; virus-like particle; Alzheimer's disease; Norovirus; P particle; Amyloid β1-6;
Preferential retrotransposition in aging yeast mother cells is correlated with increased genome instability
Keywords: ddPCR; droplet digital PCR; GCR; gross chromosomal rearrangement; LTR; long terminal repeat; MSS; Ma-Sandri-Sarkar; N&B; two-photon scanning number & brightness; ORF; open reading frame; qPCR; quantitative PCR; VLP; virus-like particle; WGA; wheat germ ag
The assembly conformation of rotavirus VP6 determines its protective efficacy against rotavirus challenge in mice
Keywords: Rotavirus; Protein assembly; VLP; VP6; Vaccine; Challenge;
Antibody avidity measurements in recipients of Cervarix® vaccine following a two-dose schedule or a three-dose schedule
Keywords: VLP; virus-like particle; AI; avidity index; GM; geometric mean; GMC; geometric mean concentration; Human papillomavirus; Vaccine; Antibodies; Avidity; Cervical cancer;
Development and application of a reversed-phase high-performance liquid chromatographic method for quantitation and characterization of a Chikungunya virus-like particle vaccine
Keywords: RP-HPLC; Vaccine; VLP; Chikungunya; CHIKV; Analytical characterization
Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial
Keywords: cLIA; Merck competitive Luminex immunoassay; EIA; enzyme immunoassay; GMT; geometric mean titre; mMU; milli-Merck units; NT100; 100% neutralization endpoint; NT90; 90% neutralization endpoint; NTpartial; partial neutralization endpoint; PsV NAb; pseudovir
Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine
Keywords: HBc; hepatitis B virus core protein; HBcAg; hepatitis B virus core antigen; HBV; hepatitis B virus; HBc-N144; N-terminal 144 amino acids of HBc; HBcL2; HBc-N144-PA-loop2; LeTx; Lethal toxin; MIR; major immunodominant region; PA; protective antigen; rPA; r
Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18
Keywords: BPV; bovine papilloma virus; cLIA-4; HPV6, 11, 16 & 18 competitive Luminex immunoassay; cLIA-9; HPV6, 11, 16, 18, 31, 33, 45, 52 & 58 competitive Luminex immunoassay; DKFZ; Deutsches Krebsforschungszentrum Laboratory (Heidelberg, Germany); HPV; human papi
Proliferation and copy number variation of BEL-like long terminal repeat retrotransposons within the Diabrotica virgifera virgifera genome
Keywords: A; alanine; BAC; bacterial artificial chromosome; BRSD; Brookings, South Dakota population; cad; cadherin gene; CDD; conserved domain database; CNV; copy number variation; D; aspartic acid; DOC; depth of coverage; E; glutamic acid; env; envelope gene; EST
Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines
Keywords: Plant-made vaccines; Plant-specific glycans; Allergy; Influenza A virus; Humoral response; IgG; IgE; CCDs; Cross-reactive carbohydrate determinants; Bromelain assay; CCD; cross-reactive carbohydrate determinants; HA; hemagglutinin; IgG/E; immunoglobulin G
Efficacy of the HPV-16/18 vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial
Keywords: ATP; according to protocol; AE; adverse event; CI; confidence interval; CIN2+; cervical intraepithelial neoplasia 2 or more severe disease; CVT; Costa Rica HPV-16/18 vaccine trial; GMT; geometric mean titer; HPV; human papillomavirus; DEIA; SPF10 HPV DNA
Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7Â T
Keywords: AV; Anterior ventral nucleus; CM; Center median nucleus; CNR; Contrast-to-noise ratio; COM; Center of mass; CSF; Cerebro-spinal fluid; GM; Gray matter; Hb; Habenular nucleus; ICC; Intraclass correlation coefficient; LD; Lateral dorsal nucleus; LGN; Latera
Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: Results from two randomized trials
Keywords: AE; adverse event; ANOVA; analysis of variance; ATP; according-to-protocol; CD40L; CD40 ligand; CI; confidence interval; CIN; cervical intraepithelial neoplasia; Ctrl; control; ELISA; enzyme-linked immunosorbent assay; EU; ELISA units; GMT; geometric mean
Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil
Keywords: HPV seroprevalence; HIV/AIDS; Pregnancy; VLP; Brazil; Q vaccine;
A second-generation ELISA (STRATIFY JCV⢠DxSelectâ¢) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification
Keywords: PML; progressive multifocal leukoencephalopathy; JCV; JC virus; ELISA; enzyme-linked immunosorbent assay; MS; multiple sclerosis; STRATA; Safety of Tysabri Re-dosing and Treatment; VLP; virus-like particles; PBS; phosphate-buffered saline; nOD; normalized
Generation of a parvovirus B19 vaccine candidate
Keywords: Vaccine; Parvovirus B19; Virus-like particle; VLP;
Hepatitis B virus-like particles access major histocompatibility class I and II antigen presentation pathways in primary dendritic cells
Keywords: VLP; virus like particle; HBsAgS; small hepatitis B virus envelope protein; pDC; plasmacytoid DC; HBV; hepatitis B virus; LCMV; lymphocytic choriomeningitis virus; OVA; ovalbumin; RHDV; rabbit hemorrhagic disease virus; TCR; T cell receptor; Hepatitis B v
Interleukin 2-inducible T cell kinase (ITK) facilitates efficient egress of HIV-1 by coordinating Gag distribution and actin organization
Keywords: ITK; Interleukin 2-inducible T cell kinase; Gag; HIV-1 group-specific antigen; MVB; multivesiclar bodies; VSV-G; vesicular stomatitis virus glycoprotein; PLAP; placental alkaline phosphatase; VLP; virus like particles; HIV; ITK; Tec kinases; Gag; Actin; V
Atom transfer radical polymerization on the interior of the P22 capsid and incorporation of photocatalytic monomer crosslinks
Keywords: VLP; P22 virus like particle; ATRP; Atom transfer radical polymerization; Ruthenium(5-methacrylamido-phenanthroline)32+; TRIS-acrylamide; Aminoethyl methacrylate; AEMA;
The antigenic architecture of the hemagglutinin of influenza H5N1 viruses
Keywords: H5N1; Hemagglutinin; Clade; Monoclonal antibody; Epitope mapping; aa; amino acid; CDC; Centre for Disease Control; ELISA; enzyme-linked immunosorbant assay; FDA; Federal Drug Administration; GFPDL; Genome Fragment Phage Display Libraries; HA; hemagglutini
Auditory neuroscience in fruit flies
Keywords: Auditory system; Neural circuit; Drosophila; Ear; Anatomy; JO; Johnston's organ; UAS; upstream activation sequence; AMMC; antennal mechanosensory and motor center; VLP; ventrolateral protocerebrum; GFP; green fluorescent protein; eYFP; enhanced yellow flu
Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses
Keywords: Influenza; Virus-like particle; VLP; Vaccine; Trivalent; Avian influenza
Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice
Keywords: HCV vaccine; DNA; VLP; Neutralizing antibody; Prime-boost
Virus-like particles: Promising platforms with characteristics of DIVA for veterinary vaccine design
Keywords: DIVA; VLP; Vaccine; Diagnostics; Animal virus
Human Papillomavirus Vaccines – Immune Responses
Keywords: HPV; virus like particle; VLP; antibody; B cells; L1 protein; L2 protein; cell mediated immunity
Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV
Keywords: IBDV; infectious bursal disease virus; 5EPIS; a polypeptide consisting of 5 epitopes, actually mimotopes, of IBDV VP2 protein linked in tandem with short amino acid spacers; HBc; hepatitis B core protein; VLP; virus-like particles; Infectious bursal disea
Neurohypophyseal hormones protect against pentylenetetrazole-induced seizures in zebrafish: Role of oxytocin-like and V1a-like receptor
Keywords: V1A; vasopressin receptor type 1; OT; oxytocin; IT; isotocin; AVP; vasopressin; AVT; vasotocin; PTZ; pentylenetetrazole; VLP; valproate sodium salt; HPA; hypothalamic-pituitary-adrenal axis; Epilepsy; Anticonvulsant; Neurohypophyseal; Hormone; Teleost
Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus
Keywords: Virus-like particle; VLP; Norovirus; P domain protein; Diagnostics;
Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma
Keywords: JCV; JC virus; PML; progressive multifocal leukoencephalopathy; ELISA; enzyme-linked immunosorbent assay; VLP; virus-like particles; nOD; normalized optical density; QC; quality controls; PC; positive control; NC; negative control; Anti-JC virus (JCV) ant
Virus-like particles: potential veterinary vaccine immunogens
Keywords: VLP; Self-assembly; Veterinary vaccine; Baculovirus; Animal virus; Immunogen;
Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]
Keywords: Vaccination; Influenza; Adjuvant; High avidity; VLP;
Highly potent delivery method of gp160 envelope vaccine combining lentivirus-like particles and DNA electrotransfer
Keywords: VLP; Electroporation; Electrotransfer; HIV vaccine; DNA vaccine
Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41
Keywords: HIV; VLP; Neutralizing antibodies; gp41; ADCC